Work

Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment in Metastatic Urothelial Cancer: A Randomized Phase II Study of Two Alternative Dosing Schedules

Year: 2026

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Clinical Genitourinary Cancer

DOI: 10.1016/j.clgc.2026.102577

Institutions: Memorial Sloan Kettering Cancer Center, Rabin Medical Center, University of Chicago, The Ohio State University

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: American Society of Clinical Oncology, National Institutes of Health, National Cancer Institute

Awards: SPORE in Bladder Cancer, Cancer Center Support Grant

OpenAlex ID: W7160442219

FWCI:

Cites: 40

Cited by:

Related to: 10